Arrhythmia Cohort Study

ConditionArrhythmia
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorBeijing Anzhen Hospital

About this trial

The goal of this prospective, observational registry study is to evaluate the long-term effectiveness, safety, and impact of different kinds of treatment on the quality of life across diverse arrhythmia subtypes and patient populations in hospitalized adults with cardiac arrhythmias (including atrial fibrillation, atrial flutter, supraventricular tachycardia, and ventricular arrhythmias) undergoing routine clinical care.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients hospitalized for any type of arrhythmia

Disqualifiers

Patients currently participating in interventional clinical trials that may confound data collection or outcome assessment in this study.

Trial population

Patients hospitalized for various types of arrhythmia

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Normal treatment with catheter ablation or medicine

    Device

    Routine clinical care with catheter ablation and/or medicine; real-world clinical cases

  • Drug Treatment

    Drug

    Routine clinical care with medicine; real-world clinical cases

Treatment groups

10,000 Participants
are divided into 1 treatment group
Group A: Treatment2 interventions

Trial outcomes

Primary outcomes

1

Arrhythmia recurrence

Recurrence of the arrhythmia after treatment

Time frame
1 year
2

All-cause death

Death due to any reason

Time frame
1 year

Secondary outcomes

1

Arrhythmia recurrence

Recurrence of the arrhythmia after treatment

Time frame
5 year
2

All-cause death

Death due to any reason

Time frame
5 year
3

Cardiovascular death

Death due to cardiovascular disease

Time frame
1 year
4

Cardiovascular death

Death due to cardiovascular disease

Time frame
5 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: